Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

76 results about "Streptomyces coelicolor" patented technology

Streptomyces coelicolor is a soil-dwelling Gram-positive bacterium that belongs to the genus Streptomyces.

Phospholipase A2 mutant and preparation method thereof

The invention relates to a phospholipase A2 mutant and a preparation method thereof. The technical scheme is as follows: the preparation method comprises the following steps: carrying out site-specific mutagenesis on the amino acid residues of Glu37 and Asp78 of wild type phospholipase A2 derived from streptomyces coelicolor by utilizing a recombinant DNA technology to obtain a phospholipase A2 gene with higher activity; then expressing the phospholipase A2 gene with higher activity in a bacillus subtilis expression system and a pichia pastoris expression system (which comprises a pichia pastoris free expression system and a pichia pastoris cell surface display system) to obtain a recombinant strain capable of generating high-activity phospholipase A2; after the phospholipase A2 gene with higher activity is expressed, detecting that the enzyme activity of the high-activity phospholipase A2 is enhanced by 13.7% compared with that of the wild type phospholipase A2, wherein the enzyme activity of the phospholipase A2 can be up to 53.5 U/ml after the bacillus subtilis high-activity phospholipase A2 recombinant bacteria is fermented, the enzyme activity of pichia pastoris free-expression high-activity phospholipase A2 recombinant bacteria can be up to 106.4 U/ml, and the enzyme activity of a pichia pastoris cell surface display high-activity phospholipase A2 whole-cell catalyst can be up to 260 U/(g.stem cell).
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Construction and application of multiple gene coexpression system containing angolosamine glycosylsynthetase and glycosyltransferase

The invention provides construction and application of a multiple gene co-expression system containing angolosamine glycosylsynthetase and glycosyltransferase. The invention is characterized by taking a streptomyces genome bank plasmid as a template; amplifying six angolosamine synthetase genes and a glycosyltransferase gene through PCR and connecting the genes in sequence and placing the genes in the lower reaches of a streptomyces promoter PactIII-actI to form a transcription unit; transferring the transcription unit to a streptomyces plasmid carrier pSET152, thus constructing a streptomyces expression plasmid pAYT55 co-expressed by multiple genes; leading the pAYT55 into a host cell streptomyces coelicolor CH999, mixedly culturing obtained engineering bacteria and streptomyces B135 of accumulated polyketide kalafungin, thus realizing bioconversion of kalafungin into a novel antibiotic with angolosamine; or directly leading pAYT55 into the streptomyces B135 and carrying out single culture to realize glycosylation of kalafungin. Therefore, by adopting the system, rare angolosamine can be synthesized in the cell and angolosamine modification can be carried out on polyketide by adopting the low substrate recognition specificity of antibiotic glycosyltransferases.
Owner:HUAZHONG NORMAL UNIV

Genetic engineering bacterium capable of promoting biological synthesis of medermycin and application thereof

The invention provides a genetic engineering bacterium capable of promoting the synthesis of antibiotic medermycin and a method for producing the medermycin by using the same. The method comprises the steps that by taking deoxyribonucleic acid (DNA) of a genome of Streptomyces nashvillensis AM-7161 as a formwork and utilizing degenerate primers to conduct polymerase chain reaction (PCR) amplification, a new complete sequence of genes of ribosome recycling factors (RRFs) of the Streptomyces is obtained; the genes are downstream placed on an efficient promoter PtipA of the Streptomyces, so that a plasmid pHSL56.2 capable of efficently expressed in the Streptomyces is constructed; the pHSL56.2 is led into the host cell Streptomyces AM71-61, and then an engineering bacterium AM71-61/pHSL56.2 (with a preservation number of CCTCCNo:M2012093) is obtained; and when the engineering bacterium AM71-61/pHSL56.2 is used to conduct solid fermentation and liquid fermentation, the accumulation of the antibiotic medermycin can be effectively promoted. The efficient expression plasmid pHSL56.2 of the genetic engineering bacterium can also be directly led into a Streptomyces strain cell for producing other antibiotics of a benzoisochromanequinones family or other aromatic polyketide antibiotics, so as to obtain corresponding antibiotic high-yield engineering bacteria. By utilizing the method, the antibiotic high-yield bacteria can be genetically bred, so that the synthetic capability of the antibiotics is enhanced.
Owner:HUAZHONG NORMAL UNIV

Secondary approach transformation method based on instruction of FK506 production bacterial strain wave chain streptomycete genome scale metabolic network model

The invention discloses a secondary approach transformation method based on an instruction of an FK506 production bacterial strain wave chain streptomycete genome scale metabolic network model. The model is based on annotation genes and physiology and biochemistry information. By comparing and analyzing the model with a streptomyces coelicolor genome, metabolic genes are found being highly conservative. Metabolic flux analysis is performed on a genome scale metabolic network, and therefore the model predicts a mutation bacterium secondary approach gene cluster transformation strategy for improving a production level. According to the secondary approach transformation method based on the instruction of the FK506 production bacterial strain wave chain streptomycete genome scale metabolic network model, the transformation method utilizes the genome scale metabolic network model to predict special structural genes in an FK506 bacterial strain secondary approach gene cluster, the production level of bacterial strains after transformation is improved by 20 percent to 90 percent, the special structural genes in the gene cluster are augmented to improve production capacity, and large application value is achieved in secondary approach rational transformation of microorganism immunosuppressor production bacterial strains. The high-efficiency and systematic method is provided for optimizing of the bacterial strains.
Owner:TIANJIN UNIV

Negative control gene of streptomyces roseoflavus as well as preparation method and application thereof

ActiveCN102634523AIncreased ability to produce antibioticsIncrease productionBiocideBacteriaGenomic DNAGenetic engineering
The invention relates to a nsdBmgh gene of streptomyces roseoflavus (Men-myco-93-63) as well as a preparation method and application thereof. The preparation method of the nsdBmgh gene of streptomyces roseoflavus comprises the following steps: automatically designing a primer Ns8F and Ns8R through the sequence of a negative control gene nsdB in the metabolic pathway of sky blue streptomycete A3(2) antibiotic, amplifying genomic DNA of the streptomyces roseoflavus (Men-myco-93-63) to obtain fragments of 1121bp, and then extending the two ends of a target sequence by utilizing a nonspecific primer anchoring PCR(NPA-PCR) method so as to obtain the nsdBmgh gene of the streptomyces roseoflavus (Men-myco-93-63). The functions of the nsdBmgh gene are verified through the gene disruption, and the bacteriostatic activity of the gene disruption mutant strain is obviously enhanced as compared with that of metabolin of original strains. The preparation and the application of the nsdBmgh gene provide an important basis for further researching and verifying the synthetic and metabolic pathway and the adjusting and controlling mechanism of the streptomyces roseoflavus, and lay the foundation for the application of high-yield genetic engineering strains of antibiotics for preventing plant diseases.
Owner:HEBEI AGRICULTURAL UNIV.
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products